February 19, 2024
Astellas Pharma and US biotech Kelonia Therapeutics have agreed to join forces in a collaboration deal aimed at developing off-the-shelf in vivo CAR-T cell therapies for cancer treatment. The Japanese pharma said on February 16 that it concluded a research...read more